Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6746 (MIR6746) is a small non-coding RNA that functions in post-transcriptional regulation of target genes. It is found extracellularly and can be detected in plasma, where its elevated expression is specifically associated with pancreatic cancer relative to other cancer types and healthy controls. MIR6746 serves as a computationally validated signature for cancer classification and is recognized as a promising biomarker for early diagnosis, patient monitoring, and potentially for future functional studies in tumorigenesis. No direct interactions with drugs have been reported for this microRNA at present, and its therapeutic targeting, while theoretically possible via RNA-based therapeutics, remains unproven in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6746 (MIR6746).